Strategic niche Strong focus on Medicare reimbursement optimization with STINGRAY SaaS and services, presenting a clear value proposition for hospitals seeking to improve Medicare revenue and data control.

Proven impact Track record of delivering over $1.3 billion in additional Medicare reimbursement across 500+ hospitals, indicating scalable results and credible ROI for potential clients.

Peer validation All four STINGRAY modules have HFMA Peer Reviewed designation, signaling quality, industry credibility, and reduced risk for prospective buyers evaluating solution legitimacy.

Acquisition opportunity Historical acquisition by TransUnion Healthcare suggests potential for alignment with large data and analytics ecosystems, enabling co-sell or integration partnerships for expanded reach.

Mid-market focus Current company size and revenue position place HPS in the mid-market hospital segment, presenting opportunities to target regional health systems and community hospitals seeking cost-efficient reimbursement optimization.